Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

DCC-2036 (Rebastinib)

InhA, Func 1020172-07-9
Catalog No. ABIN4878278

Quick Overview for DCC-2036 (Rebastinib) (ABIN4878278)

Application

Inhibition Assay (InhA), Functional Studies (Func)
  • Purpose

    DCC-2036 (Rebastinib) is a conformational control Bcr-Abl inhibitor for Abl1(WT) and Abl1(T315I) with IC50 of 0.8 nM and 4 nM, also inhibits SRC, LYN, FGR, HCK, KDR, FLT3, and Tie-2, and low activity to seen towards c-Kit. Phase 1.

    Characteristics

    Target: Bcr-Abl inhibitor
    Receptor: Abl1,FLT3,KDR,Tie-2,Lyn,Src

    Purification

    All the products are sent with COA, HPLC and NMR inspection report to guarantee the quality.

    Purity

    99.70 %

    Formula

    C30H28FN7O3

    Solubility

    200 mM in DMSO
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Format

    Solid

    Storage

    -20 °C

    Storage Comment

    For the majority of compounds, they could be dissolved in DMSO or other organic solvent.
    Their stock solution can be stored at -20°C for up to 3 months and aliquoted for sampling convenience.
    Several freeze/thaw cycles should not damage the activity of our small molecule products.
    However, in many instances the aqueous solutions of some compounds need to be made fresh and cannot be stored. For these compounds, their solution should be prepared just before use and stored no longer than 24 hours.

    Expiry Date

    24 months
  • Background

    Angiogenesis

    Molecular Weight

    553.59 g/mol

    CAS-No

    1020172-07-9
You are here:
Chat with us!